Form 8-K · Current report
Flex Ltd. 8-K, filed Aug 7, 2026
- Filed
- CIK
- 0000866374
- Accession no.
- 0000866374-26-000033
Summary
At Flex Ltd.'s 2026 annual general meeting on August 5, 2026, shareholders re-elected nine directors, re-appointed Deloitte & Touche LLP as auditors for fiscal 2027, approved executive compensation on an advisory basis, and approved mandates to issue ordinary shares and to repurchase up to 20% of shares outstanding. Flex's board authorized management to continue share repurchases of up to $2.0 billion in the open market.
Key points
- 323,004,668 of 366,389,554 ordinary shares were voted at Flex's 2026 annual general meeting on August 5, 2026.
- Shareholders approved renewal of the share purchase mandate allowing repurchases of up to 20% of issued and outstanding ordinary shares.
- Deloitte & Touche LLP was re-appointed as independent auditor for fiscal 2027.
- Michael E. Hurlston received the largest opposition of the nine director nominees, with 70,461,618 votes against.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.07Submission of Matters to a Vote of Security Holders
- 8.01Other Events
From the filing
Item 5.07 Submission of Matters to a Vote of Security Holders. On August 5, 2026, Flex Ltd. (the “Company”) held its 2026 Annual General Meeting. There were 366,389,554 Ordinary Shares entitled to be voted and 323,004,668 Ordinary Shares were voted in person or by proxy at the Annual General Meeting. At the Annual General Meeting: (1) The shareholders re-elected the nine (9) nominees for director. (2) The shareholders re-appointed Deloitte & Touche LLP as the Company’s independent auditors for the 2027 fiscal year and authorized the Company’s Board of Directors, upon the recommendation of the Audit Committee of the Board of Directors, to fix their remuneration. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.